Biomedical Engeneering | sciencenewsnet.in

Breaking News

Additional comments on extracellular vesicles derived from mesenchymal stem cells mediate extracellular matrix remodeling in osteoarthritis

Wharton’s jelly mesenchymal stem cells: Future regenerative medicine for clinical applications in mitigation of radiation injury

Current perspectives on mesenchymal stem cells as a potential therapeutic strategy for non-alcoholic fatty liver disease

Study finds targeting inflammation may not help reduce liver fibrosis in MAFLD

UF scientists study how to bring you ‘climate-smart coffee’

Moffitt Study Uncovers Key Immune Cells for Combating Aggressive Merkel Cell Carcinoma

Chula hosted “The Second Chulalongkorn University President’s Distinguished Speakers” a Special Lecture on “Revolutionizing the Future: An Exclusive Talk with “Andrew Ng” on Opportunities and Business Preparedness” by the World’s Influential AI Exper

Cleaning the window of opportunity: Towards a typology of sustainability entrepreneurs

Does information disclosure alleviate overcrowding? An empirical study based on large-scale COVID-19 nucleic acid test

Researchers develop state-of-the-art device to make artificial intelligence more energy efficient

26 Jul, 2024

Research team led by Case Western Reserve awarded $2.75M from Department of Defense to advance clot-stabilizing nanotechnology

April 12, 2024 sarah JonasAnnouncement

The U.S. Department of Defense (DoD) has awarded a team of researchers led by Case Western Reserve University a four-year, $2.75 million grant to explore new technology to generate and stabilize a protein called fibrin that is essential to maintain protective blood clots in an injured body.